Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2019 2020 2021
Months
February March May June July August September October November December
Previous Archive
19 March 2019 | Story Dr Cinde Greyling
Dr Mutana and Prof Mukwada
Many people enjoy spending time in the mountainous Drakensberg region. Prof Geofrey Mukwada’s involvement with the UFS Afromontane Research Unit (ARU) sparked an interest in sustainable tourism in the area. Pictured here are Dr Sarudzai Mutana with Prof Mukwada.
Not only is the Qwaqwa Campus situated in a beautiful region – its researchers also contribute to keeping the area pristine. Recent research by Prof Geofrey Mukwada and his PhD student, Dr Sarudzai Mutana, focused on indicators monitoring sustainable tourism development in the Drakensberg region.

Dr Mukwada is an Associate Professor in the Department of Geography on the University of the Free State (UFS) Qwaqwa Campus. 

Our majestic mountains are fragile

Many people enjoy spending time in the mountainous Drakensberg region – either as adventure seekers exploring the many trails, or just relaxing and reconnecting with nature. Prof Mukwada’s involvement with the UFS Afromontane Research Unit (ARU) sparked an interest in sustainable tourism in the area. “Mountains are fragile but attractive environments which continue to attract tourists,” he said. “Tourism is one of the major business sectors in the Drakensberg region, with promising growth opportunities and proving to be an anchor of green economy in the future – if practiced correctly.” Unfortunately, the issue of monitoring sustainable tourism has not been widely researched in African mountains. 

According to international standards

“We specifically looked at the Global Sustainable Tourism Criteria (GSTC), which is an international best-practice framework to help destinations monitor and ensure that tourism is developed in a responsible manner,” Prof Mukwada explained. “South Africa’s Manual for Responsible Tourism was designed according to some of the recommendations of the GSTC. But we found that, while the tourism and hospitality operators in the Drakensberg region appreciates the need to monitor and ensure sustainable tourism in the area, there is limited use of indicators as a tool for monitoring.” 

Forward together

There are competing demands between land-use and development practices and alternatives in the region – unless the focus shifts to sustainable practices, the short-term gains could be followed by dire consequences. “We suggest an integrated monitoring of tourism development, with a pro-poor focus that involves more local community leaders. Going forward, we would like to see the industry adopt the indicators proposed in our study.”

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 
Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept